Department of Medicine/Nephrology, Stanford University, Palo Alto, CA.
Geriatric Research Education and Clinical Center, VA Palo Alto Health Care System, Palo Alto, CA.
Transplantation. 2023 Mar 1;107(3):584-595. doi: 10.1097/TP.0000000000004297. Epub 2022 Aug 26.
Solid organ transplantation is a life-saving treatment for people with end-stage organ disease. Immune-mediated transplant rejection is a common complication that decreases allograft survival. Although immunosuppression is required to prevent rejection, it also increases the risk of infection. Some infections, such as cytomegalovirus and BK virus, can promote inflammatory gene expression that can further tip the balance toward rejection. BK virus and other infections can induce damage that resembles the clinical pathology of rejection, and this complicates accurate diagnosis. Moreover, T cells specific for viral infection can lead to rejection through heterologous immunity to donor antigen directly mediated by antiviral cells. Thus, viral infections and allograft rejection interact in multiple ways that are important to maintain immunologic homeostasis in solid organ transplant recipients. Better insight into this dynamic interplay will help promote long-term transplant survival.
实体器官移植是治疗终末期器官疾病患者的一种救生治疗方法。免疫介导的移植排斥反应是一种常见的并发症,会降低移植物的存活率。尽管免疫抑制是预防排斥反应所必需的,但它也会增加感染的风险。一些感染,如巨细胞病毒和 BK 病毒,可以促进炎症基因的表达,从而进一步使排斥反应的平衡向有利于它的方向倾斜。BK 病毒和其他感染可以诱导类似于排斥反应的临床病理学损伤,这使得准确诊断变得复杂。此外,针对病毒感染的 T 细胞可以通过抗病毒细胞直接介导的异源性免疫导致对供体抗原的排斥反应。因此,病毒感染和移植物排斥反应以多种方式相互作用,这对维持实体器官移植受者的免疫内稳态很重要。更好地了解这种动态相互作用将有助于促进长期移植的存活。